218 related articles for article (PubMed ID: 16953203)
1. Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis.
Mori T; Aisa Y; Yamazaki R; Mihara A; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2006 Nov; 38(9):637-8. PubMed ID: 16953203
[No Abstract] [Full Text] [Related]
2. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Lilleby K; Garcia P; Gooley T; McDonnnell P; Taber R; Holmberg L; Maloney DG; Press OW; Bensinger W
Bone Marrow Transplant; 2006 Jun; 37(11):1031-5. PubMed ID: 16633359
[TBL] [Abstract][Full Text] [Related]
3. [Cryotherapy is useful and safe in the prevention of oral mucositis after high-dose melphalan (L-PAM)].
Inagaki N; Ohue Y; Shigeta H; Tasaka T
Rinsho Ketsueki; 2006 Nov; 47(11):1469-71. PubMed ID: 17176891
[TBL] [Abstract][Full Text] [Related]
4. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
5. Prevention of high dose L-PAM-induced mucositis by cryotherapy.
Dumontet C; Sonnet A; Bastion Y; Salles G; Espinouse D; Coiffier B
Bone Marrow Transplant; 1994 Sep; 14(3):492-4. PubMed ID: 7994283
[No Abstract] [Full Text] [Related]
6. Prevention of high-dose melphalan-induced mucositis by cryotherapy.
Tartarone A; Matera R; Romano G; Vigliotti ML; Di Renzo N
Leuk Lymphoma; 2005 Apr; 46(4):633-4. PubMed ID: 16019498
[No Abstract] [Full Text] [Related]
7. Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients.
Aisa Y; Mori T; Kudo M; Yashima T; Kondo S; Yokoyama A; Ikeda Y; Okamoto S
Support Care Cancer; 2005 Apr; 13(4):266-9. PubMed ID: 15668755
[TBL] [Abstract][Full Text] [Related]
8. Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial.
Cho YK; Sborov DW; Lamprecht M; Li J; Wang J; Hade EM; Gao Y; Tackett K; Williams N; Benson DM; Efebera YA; Rosko AE; Devine SM; Poi M; Hofmeister CC; Phelps MA
Clin Pharmacol Ther; 2017 Sep; 102(3):511-519. PubMed ID: 28160288
[TBL] [Abstract][Full Text] [Related]
9. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
[TBL] [Abstract][Full Text] [Related]
10. Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.
Thieblemont C; Dumontet C; Saad H; Roch N; Bouafia F; Arnaud P; Hequet O; Espinouse D; Salles G; Roy P; Eljaafari-Corbin A; Du Manoir-Baumgarten C; Coiffier B
Bone Marrow Transplant; 2002 Dec; 30(11):769-75. PubMed ID: 12439700
[TBL] [Abstract][Full Text] [Related]
11. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
Chen J; Seabrook J; Fulford A; Rajakumar I
J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
[TBL] [Abstract][Full Text] [Related]
12. Use of sidestream dark-field (SDF) imaging for assessing the effects of high-dose melphalan and autologous stem cell transplantation on oral mucosal microcirculation in myeloma patients.
Milstein DM; te Boome LC; Cheung YW; Lindeboom JA; van den Akker HP; Biemond BJ; Ince C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jan; 109(1):91-7. PubMed ID: 20123381
[TBL] [Abstract][Full Text] [Related]
13. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.
Grazziutti ML; Dong L; Miceli MH; Krishna SG; Kiwan E; Syed N; Fassas A; van Rhee F; Klaus H; Barlogie B; Anaissie EJ
Bone Marrow Transplant; 2006 Oct; 38(7):501-6. PubMed ID: 16980998
[TBL] [Abstract][Full Text] [Related]
14. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
[TBL] [Abstract][Full Text] [Related]
15. Stem-cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards!
Mohty M
Leukemia; 2009 Oct; 23(10):1689-90. PubMed ID: 19826430
[No Abstract] [Full Text] [Related]
16. [Autologous stem cell transplantation in multiple myeloma - pro].
Goldschmidt H
Dtsch Med Wochenschr; 2009 Sep; 134(39):1942. PubMed ID: 19760555
[No Abstract] [Full Text] [Related]
17. Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.
Spencer A; Horvath N; Gibson J; Prince HM; Herrmann R; Bashford J; Joske D; Grigg A; McKendrick J; Prosser I; Lowenthal R; Deveridge S; Taylor K;
Bone Marrow Transplant; 2005 May; 35(10):971-7. PubMed ID: 15778725
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study.
de Paula Eduardo F; Bezinelli LM; da Graça Lopes RM; Nascimento Sobrinho JJ; Hamerschlak N; Correa L
Hematol Oncol; 2015 Sep; 33(3):152-8. PubMed ID: 24519448
[TBL] [Abstract][Full Text] [Related]
19. High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later.
Lazarus HM; Phillips GL; Herzig RH; Hurd DD; Wolff SN; Herzig GP
J Clin Oncol; 2008 May; 26(14):2240-3. PubMed ID: 18467711
[No Abstract] [Full Text] [Related]
20. Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCT.
Khaled Y; Al-Hazzouri A; Mizrachi A; Reynolds R; Reddy V; Solh M
Bone Marrow Transplant; 2013 Feb; 48(2):310-1. PubMed ID: 22773127
[No Abstract] [Full Text] [Related]
[Next] [New Search]